Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    15994402 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Escalating and Cumulative-Dose Study of Pharmacokinetics (PK), Pharmacodynamics (PD) and Safety of A006
Conditions: Asthma;   Bronchospasm;   Chronic Obstructive Pulmonary Disease (COPD)
Interventions: Drug: Albuterol Inhalation Powder;   Drug: Placebo Control;   Drug: Active Comparator
2 Completed AMP-BPT and His-BPT for Assessment of Asthma
Condition: Asthma
Intervention: Drug: inhaled corticosteroids (usually budesonide/fomorterol 160/4.5mcg; fluticasone/salmeterol 250/50mcg)

Indicates status has not been verified in more than two years